HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Terbutaline (Brethaire)

Subscribe to New Research on Terbutaline

A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.

Also Known As:

Brethaire; Brethine; Bricanyl; Aliud Brand of Terbutaline Sulfate; Alpharma Brand of Terbutaline Sulfate; Arubendol; Asthmoprotect; AstraZeneca Brand of Terbutaline Sulfate; Azupharma Brand of Terbutaline Sulfate; Bricanyl SA; Butaliret; Butalitab; Contimit; Dermapharm Brand of Terbutaline Sulfate; Estedi Brand of Terbutaline Sulfate; Fatol Brand of Terbutaline Sulfate; Hexal Brand of Terbutaline Sulfate; Hoechst Brand of Terbutaline Sulfate; KWD-2019; Kendrick Brand of Terbutaline Sulfate; Lagap Brand of Terbutaline Sulfate; Lindopharm Brand of Terbutaline Sulfate; Monovent; Novartis Brand of Terbutaline Sulfate; Stadapharm Brand of Terbutaline Sulfate; Taziken; Tedipulmo; Terbasmin; Terbul; Terbutalin AL; Terbutalin Stada; Terbutalin-ratiopharm; Terbutaline Sulfate; Terbuturmant; ct-Arzneimittel Brand of Terbutaline Sulfate; pharma-stern Brand of Terbutaline Sulfate; ratiopharm Brand of Terbutaline Sulfate; terbutalin von ct; KWD 2019; KWD2019; Terbutalin ratiopharm; ct Arzneimittel Brand of Terbutaline Sulfate; 1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-

Networked: 988 relevant articles (100 outcomes, 168 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1.	Slotkin, Theodore A: 11 articles (03/2013 - 12/2003)
2.	Seidler, Frederic J: 10 articles (03/2013 - 12/2003)
3.	Choucair-Jaafar, Nada: 4 articles (02/2014 - 11/2009)
4.	Barrot, Michel: 4 articles (02/2014 - 11/2009)
5.	Freund-Mercier, Marie-José: 4 articles (02/2014 - 11/2009)
6.	Bengtsson, Thomas: 4 articles (05/2006 - 10/2004)
7.	Selroos, Olof: 3 articles (01/2014 - 01/2006)
8.	Elliott, John P: 3 articles (03/2013 - 10/2004)
9.	Crowther, Caroline A: 3 articles (01/2013 - 01/2010)
10.	Zimmerman, Andrew W: 3 articles (12/2011 - 11/2005)

Related Diseases

1.	Asthma (Bronchial Asthma) 04/01/1988 - "In patients with nocturnal asthma treatment with a high dose of slow-release terbutaline given as a single dose in the evening appears to be effective." 10/01/1987 - "The study shows that oral sustained release terbutaline can be useful in the treatment of nocturnal asthma without impairment of sleep quality." 08/01/1998 - "was more effective in improving PEF and offered better asthma control than either terbutaline Turbuhaler, 0.5 mg q.i.d. " 10/01/1987 - "We conclude that both the intravenous and inhalational administration of terbutaline are effective in acute severe asthma, but that the intravenous route is possibly better for increasing PaO2." 01/01/1973 - "Terbutaline: a preliminary report of its pharmacological properties and therapeutic efficacy in asthma."
2.	Premature Obstetric Labor (Premature Labor) 07/01/2003 - "In this population, continuous subcutaneous terbutaline infusion was both a clinically beneficial and cost-effective treatment following recurrent preterm labor." 10/01/2004 - "The purpose of this study was to determine the frequency of serious adverse events in patients receiving continuous subcutaneous terbutaline after arrested preterm labor. " 06/01/2003 - "This study was undertaken to study the effectiveness of continuous subcutaneous terbutaline (SQT) in the home after recurrent preterm labor (RPTL). " 01/01/2002 - "Randomized trials comparing terbutaline pump maintenance therapy with alternative therapy, placebo, or no therapy after threatened preterm labor. " 02/01/1990 - "The aim of this study was to examine the fetal hemodynamic effects of terbutaline treatment and premature labor. "
3.	Chronic Obstructive Pulmonary Disease (COPD) 07/01/1988 - "Thus, oral terbutaline produces significant improvement in biventricular systolic pump performance at rest, and increases left ventricular ejection fraction during submaximal exercise in patients with moderate to severe COPD." 07/01/1991 - "5. We conclude that in severe COAD regular nebulised terbutaline 5 mg four times a day produces a sustained improvement in baseline lung function without changes in dose-response which would suggest tolerance." 10/15/2003 - "The use of terbutaline applied by a subcutaneous pump in addition to standard therapy may be helpful in severely ill patients suffering from COPD. " 11/28/2011 - "Chronic obstructive pulmonary disease patients requiring NIV received randomised study doses of either 2mg terbutaline nebulised from an Aeroneb Pro (AERO) or 5mg from a Sidestream (SIDE) on days 1 and 3 of admission. " 09/01/1996 - "To evaluate the short-term effects of inhaled terbutaline on breathlessness, breathing pattern, and P0.1 in patients with nonreversible COPD, we designed a randomized, double-blind, parallel, placebo-controlled study. "
4.	Status Asthmaticus 06/01/1998 - "The data showed, preliminarily, that (a) the system for continuous nebulization of terbutaline sulphate was effective in treatment of children's acute asthmatic crises, and (b) there was evidence attesting to the absorption of terbutaline sulphate by the children treatment with it." 10/01/1977 - "We conclude that terbutaline is effective in the treatment of status asthmaticus, with only modest effects on the cardiovascular system." 06/01/1998 - "This study investigated the efficacy of a system for continuous nebulization of terbutaline sulphate in the treatment of acute asthmatic crises in children. " 10/01/2011 - "This was a prospective observational study in 20 consecutive patients who were admitted to a tertiary care pediatric intensive care unit for status asthmaticus and received intravenous terbutaline. " 10/01/2011 - "Elevated cTnI concentrations were observed in 50% of patients treated with intravenous terbutaline for status asthmaticus. "
5.	Exercise-Induced Asthma (Asthma, Exercise Induced) 09/26/1994 - "It is concluded that continuous treatment, even with high doses or oral terbutaline, does not offer clinically useful protection against exercise-induced asthma." 04/01/1993 - "It is concluded that continuous treatment, even with high doses of oral terbutaline, does not offer clinically useful protection against exercise-induced asthma." 09/26/1994 - "We wanted to assess the protective effects on exercise-induced asthma as well as the clinical efficacy and safety of increasing doses of a new sustained-release formulation of terbutaline sulphate in 17 asthmatic children aged 6-12 years (mean 9 years). " 04/01/1993 - "We wanted to assess the protective effects on exercise-induced asthma as well as the clinical efficacy and safety of increasing doses of a new sustained-release formulation of terbutaline sulphate, in 17 asthmatic children aged 6-12 yrs (mean 9 yrs). " 04/01/1993 - "No protection by oral terbutaline against exercise-induced asthma in children: a dose-response study."

Related Drugs and Biologics

1.	Albuterol (Salbutamol)
2.	Budesonide (Pulmicort)
3.	formoterol (Oxis)
4.	Theophylline (Theon)
5.	Epinephrine (Adrenaline)
6.	Magnesium Sulfate (Sulfate, Magnesium)
7.	Ritodrine (Yutopar)
8.	Terbutaline (Brethaire)
9.	Aminophylline (Carine)
10.	Fenoterol

Related Therapies and Procedures

1.	Nebulizers and Vaporizers (Inhaler)
2.	Metered Dose Inhalers (Metered Dose Inhaler)
3.	Tocolysis
4.	Aftercare (After-Treatment)
5.	Intravenous Infusions